SYSTEMIC SCLEROSIS
Clinical trials for SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early-Stage lung blood pressure drug trial halted
Disease control TerminatedThis study tested the drug riociguat in people with early pulmonary vascular disease, a condition where blood vessels in the lungs narrow, making the heart work harder. The trial included 35 adults with connective tissue disease or an inherited form. Participants received either …
Matched conditions: SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
Study explores vaccine protection in patients on Immune-Suppressing meds
Knowledge-focused TerminatedThis study aimed to measure how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers planned to enroll 78 adults, but the study was stopped early. The goal was to understand …
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC
-
Tiny study on drug monitoring in scleroderma ends early
Knowledge-focused TerminatedThis study aimed to find the best level of a drug called mycophenolate mofetil (MMF) in the blood to improve skin tightness and lung function in people with systemic sclerosis. Only 2 people joined before the study was stopped early. The research was designed to see if measuring …
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC